Dinçer, B. T., Usta, A. M., Kural, A., Helvacı, N., Uçar, A., & Urgancı, N. Correction: Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents? BMC.
Chicago Style (17th ed.) CitationDinçer, Büşra Tetik, Ayşe Merve Usta, Alev Kural, Nazlı Helvacı, Ahmet Uçar, and Nafiye Urgancı. Correction: Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease in Obese Adolescents? BMC.
MLA (9th ed.) CitationDinçer, Büşra Tetik, et al. Correction: Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease in Obese Adolescents? BMC.
Warning: These citations may not always be 100% accurate.